Loading clinical trials...
Loading clinical trials...
Evidence is emerging that those patients with cyanotic pathologies may be more vulnerable to end-organ injury during and after surgery than those patients without, because of compromised cardiopulmona...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Nanjing Medical University
NCT06932081 · Adult Congenital Heart Disease, Congenital Heart Disease, and more
NCT00243776 · Congenital Heart Disease, Tetralogy of Fallot
NCT06668389 · Congenital Heart Disease, Repaired Tetralogy of Fallot (rTOF), and more
NCT05809310 · Transposition of Great Vessels, Tetralogy of Fallot, and more
NCT03837574 · Tetralogy of Fallot, Implantable Defibrillator User, and more
TEDA International Cardiovascular Hospital
Tianjin, Tianjin Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions